Phase II Study of Everolimus (RAD001) in Children and Adults With Neurofibromatosis Type 2
Clinical trial NCT01419639 · COMPLETED
Trial details
- NCT number
- NCT01419639
- Sponsor
- NYU Langone Health
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-10-01
- Primary completion
- 2012-12-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.